Microarray expert Affymetrix is to buy molecular biology reagent
firm USB Corporation for $75m (€52m) in a bid to accelerate the
development of new genetic analysis tools.
Illumina's third quarter revenues soared 82 per cent while
Affymetrix looked to bolster its slice of the genetics market by
filing more patent infringement claims against the young pretender.
LabTechnologist.com brings you a round up of recent industry news,
with developments at Affymetrix, Celera, deltaDOT, Eksigent,
Farfield, Nanogen and Olympus UK.
Affymetrix has extended the range of custom microarrays it offers
to customers with the launch of the NimbleExpress Array Programme,
which caters for users that require fewer units.